top of page
PangramSansMedium.png
light hero.jpg

Restoring Balance, Transforming Neurology

We are harnessing the power of light to develop a precision neuromodulation platform using optogenetics to treat severe neurological disorders.

shutterstock_1099386764.jpg
Our Mission

At Modulight Biotherapeutics we are pioneering a new era of brain medicine for people living with neurological disorders - one that is fast-acting, precise, and designed to provide real relief without side effects.  Our mission is to help patients regain function and comfort in moments that matter most—whether it’s stopping a seizure, calming a tremor, or easing persistent pain.

OptiBranShadow_edited.png
TRIGEMINAL NEURALGIA

Our first indication for clinical studies will be debilitating neuropathic pain. The location of the trigeminal nerve makes it an ideal candidate for protein sensitive light therapy.

News & Publications

"Novel OptoGPCRs open new avenues in optogenetic modulation"

SPIE Photonics West Daily. (2025)

"Exploring GPCR-mediated optogenetic modulation of seizure networks in a pig model of Temporal Lobe Epilepsy"

Chang, S., Bar-Or, K.L., Mivalt, F., Maltais, D., Kfir, Y., Kim, J., Kim, I., Hershko, M., Daily, J., Swissa, E., Levi, O., Devore, S., Yizhar, O., Eldar, Y., & Worrell, G. 

bioRxiv, (2025)

"Efficient optogenetic silencing of neurotransmitter release with a mosquito rhodopsin"

Mahn, M., Saraf-Sinik, I., Patil, P., … Lüthi, A., Rost, B.R., Wiegert, J.S. & Yizhar O. 

Neuron. 109, 10, p. 1621-1635.e8, (2021) 

Our Research Partners

WeizmannRed.png
ShebaRed.png
UniFloridaRedpng.png
MayoCLinicRedpng_edited.png
GladStonesRed.png
MichiganRed.png
Kings Red.png
Background Circles.png
bottom of page